Assistant Professor, Pathology and Laboratory Medicine, Emory University School of Medicine

Pathology

Adams practices Pathology. He researched medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare. Adams is also a published MD. He has 26 publication published. The most recent publication is: Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

Publications

---

• The Predictive Ability of a CK5/p63/CK8/18 Antibody Cocktail in Stratifying Breast Papillary Lesions on Needle Biopsy: An Algorithmic Approach Works Best.
• Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation.
• Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.
• GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance.
• Commonly encountered dilemmas in breast cancer reporting and staging.
• Acidophilic nuclear inclusions are specific for florid ductal hyperplasia among proliferative breast lesions.
• Proliferation (Ki-67 and Phosphohistone H3) andOncotype DX Recurrence Score in Estrogen Receptor-positiveBreast Cancer.
• Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5/p63/cytokeratin 8/18 antibody cocktail in thei...
• Breast arterial calcification: a marker of medial vascular calcification in chronic kidney disease.
• Nuclear grade and survival in invasive lobular carcinoma: a case series with long-term follow-up.
• Attenuated podoplanin staining in breast myoepithelial cells: a potential caveat in the diagnosis of lymphatic invasion.
• Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
• Effect of storage on p63 immunohistochemistry: a time-course study.
• Using a higher cutoff for the percentage of HER2+ cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis.
• Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry.
• The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma.
• Solid pseudopapillary tumor of the pancreas: a review of salient clinical and pathologic features.
• Does using a higher cutoff for the percentage of positive cells improve the specificity of HER-2 immunohistochemical analysis in breast carcinoma?
• Granulomatous interstitial nephritis secondary to histoplasmosis.
• Mucoepidermoid carcinoma of the bronchus: a review.
• Negative colposcopic biopsy after positive human papilloma virus (HPV) DNA testing: false-positive HPV results or false-negative histologic findings?
• Clinical significance of unsatisfactory conventional pap smears owing to inadequate squamous cellularity defined by the Bethesda 2001 criterion.
• Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
• Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.
• Pleural amyloidosis mimicking mesothelioma: a clinicopathologic study of two cases.

Schools

---

• University Of Alabama School Of Medicine

• University Al

• University Ala Birmingham Clin

Doctors Specialties

---

• Family Medicine
• Pathology

Accepted Insurances

---

• Aetna
• Amerigroup (Wellpoint)
• Assurant Health
• Cigna
• Commercial Insurance Company
• CoreSource
• Coventry Health Care
• GEHA
• Humana
• Kaiser Permanente
• Mail Handlers Benefit Plan (MHBP)
• Medicaid
• Medicare MCR
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• United Healthcare

Education

---

• University of Alabama Medical Center
• University of Alabama School of Medicine

Hospital

---

• Emory University Hospital

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1124072939
Last Name Of The Provider	ADAMS
First Name Of The Provider	AMY
View All

Similar Doctors

---

	Dr. Jarod E. Speer, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth C. Stevenson, MD This Doctor is OpenDoctor Recommended.
	Dr. John B. Culpepper, MD This Doctor is OpenDoctor Recommended.
	Dr. Marisol S. Sanchez-Lance, DO
	Dr. Neil R. Meadows, MD
	Dr. Vishal A. Mandge, MD
	Dr. James M. Lance Jr., DO This Doctor is OpenDoctor Recommended.
	Dr. Sara A. Song, MD
	Dr. Stuart K. Bean, MD This Doctor is OpenDoctor Recommended.
	Jonathan A. Dean
	Dr. Samuel A. Cherry III, MD This Doctor is OpenDoctor Recommended.
	Dr. Oscar Cummings, MD This Doctor is OpenDoctor Recommended.
	Dr. William E. Grizzle, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Shuko Harada, MD This Doctor is OpenDoctor Recommended.
	Dr. Robinna G. Lorenz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Boris Datnow, MD
	Dr. Jeremy W. Henderson, MD This Doctor is OpenDoctor Recommended.
	Dr. Chris J. Kulhavy, MD
	Dr. Thomas S. Winokur, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin A. Roth, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Christina J. Tatum, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog